Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Samsung |
Recipient: You |
Company: Celtrion |
Recipient: You |
Company: PUMA |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Macrogenics |
Recipient: Your Institution |
Company: OBI Pharma |
Recipient: Your Institution |
Company: Eisai |
Recipient: Your Institution |
Company: Pfizer |
Recipient: Your Institution |
Company: Novartis |
Recipient: Your Institution |
Company: Lilly |
Recipient: Your Institution |
Company: Genentech |
Recipient: Your Institution |
Company: Merck |
Recipient: Your Institution |
Company: Immunomedics |
Recipient: Your Institution |
Company: Odonate Therapeutics |
Recipient: Your Institution |
Company: Daiichi Sankyo |
Recipient: Your Institution |
Company: Seattle Genetics |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
Company: Pfizer |
Recipient: You |
Company: Novartis |
Recipient: You |
Company: Macrogenics |
Recipient: You |
Company: Mylan |
Recipient: You |
Company: Daiichi Sankyo |
Recipient: You |
Company: AstraZeneca Spain |
Recipient: You |
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
No Relationships to Disclose |
|
|
(OPTIONAL) Open Payments Link |
|
Open Payments URL: https://openpaymentsdata.cms.gov/summary |
|